Therapeutic potential of ghrelin in cardiac diseases

Expert Review of Endocrinology and Metabolism

Volumn 4, Issue 3, 2009, Pages 283-289

  Kishimoto, Ichiro ^a   Tokudome, Takeshi ^a   Schwenke, Daryl O ^b   Takeshi, Soeki ^c   Hosoda, Hiroshi ^a   Nagaya, Noritoshi ^a   Kangawa, Kenji ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Appetite hormone; Arrhythmia; Ghrelin; Heart failure; Myocardial infarction; Sympathetic nerve

Indexed keywords

GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE; GROWTH HORMONE SECRETAGOGUE RECEPTOR;

AUTONOMIC NERVE; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; EFFERENT NERVE; ENDOCRINE FUNCTION; ENERGY BALANCE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HEART DEATH; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART PERFORMANCE; HEART PROTECTION; HEART RATE; HEART VENTRICLE REMODELING; HUMAN; LONG TERM CARE; LUNG ARTERY PRESSURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PULMONARY HYPERTENSION; REVIEW; SENSORY NERVE CONDUCTION; STRUCTURE ACTIVITY RELATION; SYMPATHETIC NERVE; VAGUS NERVE;

EID: 70049090993     PISSN: 17446651     EISSN: None     Source Type: Journal    
DOI: 10.1586/eem.09.7     Document Type: Review

References (39)

1. Kojima M, Hosoda H, Date Y et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402(6762), 656-660 (1999).
2. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132(3), 387-396 (2008).
3. Kojima M, Hosoda H, Matsuo H, KangawaK. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metab. 12(3), 118-122 (2001).
4. Nakazato M, Murakami N, Date Y et al. A role for ghrelin in the central regulation of feeding. Nature 409(6817), 194-198 (2001).
5. Horvath TL, Diano S, Sotonyi P, Heiman M, Tschop M. Minireview: ghrelin and the regulation of energy balance - a hypothalamic perspective. Endocrinology 142(10), 4163-4169 (2001).
6. Date Y, Murakami N, Toshinai K et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 123(4), 1120-1128 (2002).
7. Kojima M, Kangawa K. Drug insight: the functions of ghrelin and its potential as a multitherapeutic hormone. Nat. Clin. Prac. 2(2), 80-88 (2006).
8. Frascarelli S, Ghelardoni S, Ronca-Testoni S, Zucchi R. Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart. Basic Res. Cardiol. 98(6), 401-405 (2003).
9. Chang L, Zhao J, Li GZ et al. Ghrelin protects myocardium from isoproterenol-induced injury in rats. Acta Pharmacol. Sin. 25(9), 1131-1137 (2004).
10. Li L, Zhang LK, Pang YZ et al. Cardioprotective effects of ghrelin and des-octanoyl ghrelin on myocardial injury induced by isoproterenol in rats. Acta Pharmacol. Sin. 27(5), 527-535 (2006).
11. Nagaya N, Uematsu M, Kojima M et al. Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation 104(17), 2034-2038 (2001).
12. Nagaya N, Moriya J, Yasumura Y et al. Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure. Circulation 110(24), 3674-3679 (2004).
13. Henriques-Coelho T, Correia-Pinto J, Roncon-Albuquerque R Jr et al. Endogenous production of ghrelin and beneficial effects of its exogenous administration in monocrotaline-induced pulmonary hypertension. Am. J. Physiol. 287(6), H2885-H2890 (2004).
14. Gnanapavan S, Kola B, Bustin SA et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J. Endocrinol. Metab. 87(6), 2988 (2002).
15. Nagaya N, Uematsu M, Kojima M et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 104(12), 1430-1435 (2001).
16. Soeki T, Kishimoto I, Schwenke DO et al. Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction. Am. J. Physiol. 294(1), H426-H432 (2008).
17. Schwenke DO, Tokudome T, Kishimoto I et al. Early ghrelin treatment after myocardial infarction prevents an increase in cardiac sympathetic tone and reduces mortality. Endocrinology 149(10), 5172-5176 (2008).
18. Schwenke DO, Tokudome T, Shirai M et al. Exogenous ghrelin attenuates the progression of chronic hypoxia-induced pulmonary hypertension in conscious rats. Endocrinology 149(1), 237-244 (2008).
19. Takaya K, Ariyasu H, Kanamoto N et al. Ghrelin strongly stimulates growth hormone release in humans. J. Endocrinol. Metab. 85(12), 4908-4911 (2000).
20. Arvat E, Di Vito L, Broglio F et al. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J. Endocrinol. Invest. 23(8), 493-495 (2000).
21. Nagaya N, Kojima M, Uematsu M et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. 280(5), R1483-R1487 (2001).
22. Janssen JA, Poldermans D, Holland LJ et al. There are no acute cardiac effects of a single iv dose of human ghrelin in severe growth hormone deficient patients. J. Endocrinol. Invest. 27(7), 659-664 (2004).
23. Torsello A, Bresciani E, Rossoni G et al. Ghrelin plays a minor role in the physiological control of cardiac function in the rat. Endocrinology 144(5), 1787-1792 (2003).
24. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 407(6806), 908-913 (2000).
25. Wren AM, Small CJ, Ward HL et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141(11), 4325-4328 (2000).
26. Asakawa A, Inui A, Kaga T et al. A role of ghrelin in neuroendocrine and behavioral responses to stress in mice. Neuroendocrinology 74(3), 143-147 (2001).
27. Toshinai K, Mondal MS, Nakazato M et al. Upregulation of ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem. Biophys. Res. Commun. 281(5), 1220-1225 (2001).
28. 125I-His(9)]-ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with athersclerosis. Br. J. Pharmacol. 134(1), 143-149 (2001).
29. Okumura H, Nagaya N, Enomoto M et al. Vasodilatory effect of ghrelin, an endogenous peptide from the stomach. J. Cardiovasc. Pharmacol. 39(6), 779-783 (2002).
30. Wiley KE, Davenport AP. Comparison of vasodilators in human internal mammary artery: ghrelin is a potent physiological antagonist of endothelin-1. Br. J. Pharmacol. 136(8), 1146-1152 (2002).
31. Baldanzi G, Filigheddu N, Cutrupi S et al. Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J. Cell. Biol. 159(6), 1029-1037 (2002).
32. Lin Y, Matsumura K, Fukuhara M et al. Ghrelin acts at the nucleus of the solitary tract to decrease arterial pressure in rats. Hypertension 43(5), 977-982 (2004).
33. Lawrence CB, Snape AC, Baudoin FM et al. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 143(1), 155-162 (2002).
34. Date Y, Murakami N, Kojima M et al. Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem. Biophys. Res. Commun. 275(2), 477-480 (2000).
35. Peino R, Baldelli R, Rodriguez-Garcia J et al. Ghrelin-induced growth hormone secretion in humans. Eur. J. Endocrinol. 43(6), R11-R14 (2000).
36. Muccioli G, Tschöp M, Papotti M et al. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol. 440(2-3), 235-254 (2002).
37. Akamizu T, Kangawa K. Translational research on the clinical applications of ghrelin. Endocr. J. 53(5), 585-591 (2006).
38. Akamizu T, Iwakura H, Ariyasu H et al. Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite. Eur. J. Endocrinol. 158(4), 491-498 (2008).
39. Akamizu T, Iwakura H, Ariyasu H et al. Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia. J. Am. Geriatr. Soc. 56(12), 2363-2365 (2008).